144060-53-7

We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of Febuxostat (CAS No.: 144060-53-7) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Febuxostat (CAS No.: 144060-53-7)and other compounds. We can provide high-quality compounds and good service fou you.

Send Inquiry

Product Description

Name	Febuxostat
Synonyms	2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic Acid;UNII-101V0R1N2E;Febuxostat;Uloric;Adenuric;Tei-6720;TMX 67
Molecular Formula	C₁₆H₁₆N₂O₃S
Molecular Weight	316.37500
CAS Number	144060-53-7
purity	≥99%
Availability	In stock

Application: Febuxostat (INN; trade names Adenuric in Europe and New Zealand, Uloric in the US, Goturic in Latin America, Feburic in Japan) is a drug that inhibits xanthine oxidase, thus reducing production of uric acid in the body. It is used in the treatment of chronic gout and hyperuricemia.
Febuxostat was discovered by scientists at the Japanese pharmaceutical company Teijin in 1998. Teijin partnered the drug with TAP Pharmaceuticals in the US and Ipsen in Europe. Ipsen obtained marketing approval for febuxostat from the European Medicines Agency in April 2008, Takeda obtained FDA approval in February 2009, and Teijin obtained approval from the Japanese "Pharmaceuticals and Medical Devices Agency" in 2011.

Hot Tags: